Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection

類似資料

• Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection.
  著者:: Stratford, MR, 等
  出版事項: (2011)
• Quantitative determination of the anticancer prodrug combretastatin A1 phosphate (OXi4503, CA1P), the active CA1 and its glucuronide metabolites in human urine and of CA1 in plasma by HPLC with mass spectrometric detection.
  著者:: Stratford, MR, 等
  出版事項: (2012)
• Enhanced fluorescence detection of cis-combretastatins by post-column photolysis.
  著者:: Stratford, MR
  出版事項: (2008)
• A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation
  著者:: Stratford, M, 等
  出版事項: (2012)
• A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis-trans isomerisation.
  著者:: Stratford, MR, 等
  出版事項: (2012)